trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Breast Neoplasms D001943 24 associated lipids
Neoplasms D009369 13 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Carcinoma D002277 18 associated lipids
Ureteral Obstruction D014517 10 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Hypersensitivity D006967 22 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Liu H et al. Inhibition of class II histone deacetylase blocks proliferation and promotes neuronal differentiation of the embryonic rat neural progenitor cells. 2012 Acta Neurobiol Exp (Wars) pmid:23377267
Liu J et al. Direct differentiation of hepatic stem-like WB cells into insulin-producing cells using small molecules. 2013 Sci Rep pmid:23378917
Li Y et al. Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer. 2013 Mol. Cancer pmid:23379261
Laska MJ et al. (Some) cellular mechanisms influencing the transcription of human endogenous retrovirus, HERV-Fc1. 2013 PLoS ONE pmid:23382858
Bhargavan B et al. Epigenetic repression of LEDGF during UVB exposure by recruitment of SUV39H1 and HDAC1 to the Sp1-responsive elements within LEDGF promoter CpG island. 2013 Epigenetics pmid:23386123
Koch M et al. Overcoming chemotherapy resistance of ovarian cancer cells by liposomal cisplatin: molecular mechanisms unveiled by gene expression profiling. 2013 Biochem. Pharmacol. pmid:23396090
Tran HT et al. Improved therapeutic effect against leukemia by a combination of the histone methyltransferase inhibitor chaetocin and the histone deacetylase inhibitor trichostatin A. 2013 J. Korean Med. Sci. pmid:23400519
Cho JS et al. Effects of histone deacetylase inhibitor on extracellular matrix production in human nasal polyp organ cultures. 2013 Am J Rhinol Allergy pmid:23406592
Hudson RS et al. Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer. 2013 Mol. Cancer pmid:23409773
Yang F et al. Histone hyperacetylation during meiosis interferes with large-scale chromatin remodeling, axial chromatid condensation and sister chromatid separation in the mammalian oocyte. 2012 Int. J. Dev. Biol. pmid:23417411
Camolotto SA et al. PSG gene expression is up-regulated by lysine acetylation involving histone and nonhistone proteins. 2013 PLoS ONE pmid:23418492
Chen CQ et al. Pure curcumin increases the expression of SOCS1 and SOCS3 in myeloproliferative neoplasms through suppressing class I histone deacetylases. 2013 Carcinogenesis pmid:23430957
Kim YJ et al. HDAC inhibitors induce transcriptional repression of high copy number genes in breast cancer through elongation blockade. 2013 Oncogene pmid:23435418
Yeo M et al. Bisphenol A delays the perinatal chloride shift in cortical neurons by epigenetic effects on the Kcc2 promoter. 2013 Proc. Natl. Acad. Sci. U.S.A. pmid:23440186
Viñuelas J et al. Quantifying the contribution of chromatin dynamics to stochastic gene expression reveals long, locus-dependent periods between transcriptional bursts. 2013 BMC Biol. pmid:23442824
Chachadi VB et al. Prostatic cell-specific regulation of the synthesis of MUC1-associated sialyl Lewis a. 2013 PLoS ONE pmid:23451223
Duo J et al. Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line. 2013 DNA Cell Biol. pmid:23451817
Mateen S et al. Silibinin synergizes with histone deacetylase and DNA methyltransferase inhibitors in upregulating E-cadherin expression together with inhibition of migration and invasion of human non-small cell lung cancer cells. 2013 J. Pharmacol. Exp. Ther. pmid:23461975
Spallotta F et al. A nitric oxide-dependent cross-talk between class I and III histone deacetylases accelerates skin repair. 2013 J. Biol. Chem. pmid:23463510
Sachweh MC et al. Incompatible effects of p53 and HDAC inhibition on p21 expression and cell cycle progression. 2013 Cell Death Dis pmid:23470540
Miyatake Y et al. Protective roles of epithelial cells in the survival of adult T-cell leukemia/lymphoma cells. 2013 Am. J. Pathol. pmid:23474084
Hansberg-Pastor V et al. The role of DNA methylation and histone acetylation in the regulation of progesterone receptor isoforms expression in human astrocytoma cell lines. 2013 Steroids pmid:23474171
Arora DS et al. Hyposensitivity to gamma-aminobutyric acid in the ventral tegmental area during alcohol withdrawal: reversal by histone deacetylase inhibitors. 2013 Neuropsychopharmacology pmid:23474591
Lee AR et al. Nicotinamide: a class III HDACi delays in vitro aging of mouse oocytes. 2013 J. Reprod. Dev. pmid:23474603
Jung AR et al. Increased alternative lengthening of telomere phenotypes of telomerase-negative immortal cells upon trichostatin--a treatment. 2013 Anticancer Res. pmid:23482750
Zhang L et al. Effect of histone deacetylase inhibitors on cell apoptosis and expression of the tumor suppressor genes RUNX3 and ARHI in ovarian tumors. 2013 Mol Med Rep pmid:23504001
Song BS et al. Valproic acid enhances early development of bovine somatic cell nuclear transfer embryos by alleviating endoplasmic reticulum stress. 2014 Reprod. Fertil. Dev. pmid:23506644
Poplineau M et al. Epigenetically induced changes in nuclear textural patterns and gelatinase expression in human fibrosarcoma cells. 2013 Cell Prolif. pmid:23510467
Ding SZ et al. Epithelial-mesenchymal transition during oncogenic transformation induced by hexavalent chromium involves reactive oxygen species-dependent mechanism in lung epithelial cells. 2013 Toxicol. Appl. Pharmacol. pmid:23518002
Azechi T et al. Trichostatin A, an HDAC class I/II inhibitor, promotes Pi-induced vascular calcification via up-regulation of the expression of alkaline phosphatase. 2013 J. Atheroscler. Thromb. pmid:23518467
Sato A et al. Suppressive effect of the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) on hepatitis C virus replication. 2013 J. Cell. Biochem. pmid:23519646
Wang Y et al. Nuclear factor κB mediates suppression of canonical transient receptor potential 6 expression by reactive oxygen species and protein kinase C in kidney cells. 2013 J. Biol. Chem. pmid:23525112
Brown CO et al. Scavenger receptor class A member 3 (SCARA3) in disease progression and therapy resistance in multiple myeloma. 2013 Leuk. Res. pmid:23537707
Chambliss AB et al. Simultaneously defining cell phenotypes, cell cycle, and chromatin modifications at single-cell resolution. 2013 FASEB J. pmid:23538711
Yacqub-Usman K et al. Preincubation of pituitary tumor cells with the epidrugs zebularine and trichostatin A are permissive for retinoic acid-augmented expression of the BMP-4 and D2R genes. 2013 Endocrinology pmid:23539512
Khan DH and Davie JR HDAC inhibitors prevent the induction of the immediate-early gene FOSL1, but do not alter the nucleosome response. 2013 FEBS Lett. pmid:23542037
Wong CH et al. CTSL2 is a pro-apoptotic target of E2F1 and a modulator of histone deacetylase inhibitor and DNA damage-induced apoptosis. 2014 Oncogene pmid:23542171
Wang F et al. HDAC inhibitor trichostatin A suppresses esophageal squamous cell carcinoma metastasis through HADC2 reduced MMP-2/9. 2013 Clin Invest Med pmid:23544610
Sato T et al. Enhancement of inflammatory protein expression and nuclear factor Κb (NF-Κb) activity by trichostatin A (TSA) in OP9 preadipocytes. 2013 PLoS ONE pmid:23555753
Wang P et al. Trichostatin A protects against cisplatin-induced ototoxicity by regulating expression of genes related to apoptosis and synaptic function. 2013 Neurotoxicology pmid:23558232
Duncan HF et al. Histone deacetylase inhibitors epigenetically promote reparative events in primary dental pulp cells. 2013 Exp. Cell Res. pmid:23562654
Wang Y et al. Role of histone deacetylase inhibitors in the aging of human umbilical cord mesenchymal stem cells. 2013 J. Cell. Biochem. pmid:23564418
Höring E et al. The histone deacetylase inhibitor trichostatin a promotes apoptosis and antitumor immunity in glioblastoma cells. 2013 Anticancer Res. pmid:23564772
Chen CH et al. Synergistic effect of trichostatin A and scriptaid on the development of cloned rabbit embryos. 2013 Theriogenology pmid:23566670
Matsubara K et al. Dynamics and regulation of lysine-acetylation during one-cell stage mouse embryos. 2013 Biochem. Biophys. Res. Commun. pmid:23567968
Culley KL et al. Class I histone deacetylase inhibition modulates metalloproteinase expression and blocks cytokine-induced cartilage degradation. 2013 Arthritis Rheum. pmid:23575963
Elaut G et al. Rat hepatocyte suspensions as a suitable in vitro model for studying the biotransformation of histone deacetylase inhibitors. 2004 Altern Lab Anim pmid:23577441
Gang H et al. Epigenetic regulation of canonical TNFα pathway by HDAC1 determines survival of cardiac myocytes. 2013 Am. J. Physiol. Heart Circ. Physiol. pmid:23585133
Oleksiewicz U et al. Cytoglobin has bimodal: tumour suppressor and oncogene functions in lung cancer cell lines. 2013 Hum. Mol. Genet. pmid:23591990
Cong P et al. Effects of trichostatin A on histone acetylation and methylation characteristics in early porcine embryos after somatic cell nuclear transfer. 2013 Anim. Sci. J. pmid:23607426
Neumann F et al. EBV-transformed lymphoblastoid cell lines as vaccines against cancer testis antigen-positive tumors. 2013 Cancer Immunol. Immunother. pmid:23619976
Munro SK et al. Histone deacetylase inhibition by trichostatin A mitigates LPS induced TNFα and IL-10 production in human placental explants. 2013 Placenta pmid:23623485
Hayakawa K et al. Epigenetic switching by the metabolism-sensing factors in the generation of orexin neurons from mouse embryonic stem cells. 2013 J. Biol. Chem. pmid:23625921
Contreras AU et al. Deacetylation of p53 induces autophagy by suppressing Bmf expression. 2013 J. Cell Biol. pmid:23629966
Piazza R et al. Epigenetic silencing of the proapoptotic gene BIM in anaplastic large cell lymphoma through an MeCP2/SIN3a deacetylating complex. 2013 Neoplasia pmid:23633923
Yang H et al. Induction of the liver cancer-down-regulated long noncoding RNA uc002mbe.2 mediates trichostatin-induced apoptosis of liver cancer cells. 2013 Biochem. Pharmacol. pmid:23643933
Majumder A et al. Inhibition of DNA methyltransferases and histone deacetylases induces astrocytic differentiation of neural progenitors. 2013 Stem Cell Res pmid:23644509
Arbuckle JH et al. Mapping the telomere integrated genome of human herpesvirus 6A and 6B. 2013 Virology pmid:23648233
Breuzard G et al. Molecular mechanisms of Tau binding to microtubules and its role in microtubule dynamics in live cells. 2013 J. Cell. Sci. pmid:23659998
Matteucci E et al. Epigenetic control of endothelin-1 axis affects invasiveness of breast carcinoma cells with bone tropism. 2013 Exp. Cell Res. pmid:23660387
Choi S et al. Histone deacetylases inhibitor trichostatin A modulates the extracellular release of APE1/Ref-1. 2013 Biochem. Biophys. Res. Commun. pmid:23665318
Ignatius MS et al. Distinct functional and temporal requirements for zebrafish Hdac1 during neural crest-derived craniofacial and peripheral neuron development. 2013 PLoS ONE pmid:23667588
Li M et al. Upregulation of Toll-like receptor 2 gene expression by acetylation of AP-2 alpha in THP-1 cells, a human monocytic cell line. 2013 Int. J. Biochem. Cell Biol. pmid:23680675
Zhang Z et al. Stemness and inducing differentiation of small cell lung cancer NCI-H446 cells. 2013 Cell Death Dis pmid:23681228
Kannan V et al. Histone deacetylase inhibitors suppress immune activation in primary mouse microglia. 2013 J. Neurosci. Res. pmid:23686642
Di Micco S et al. Structural basis for the design and synthesis of selective HDAC inhibitors. 2013 Bioorg. Med. Chem. pmid:23693069
Xia X et al. Effects of trichostatin A in a rat model of acute graft-versus-host disease after liver transplantation. 2013 Transplantation pmid:23694951
Fan J et al. Inhibition of HDAC2 protects the retina from ischemic injury. 2013 Invest. Ophthalmol. Vis. Sci. pmid:23696608
Van Beneden K et al. Comparison of trichostatin A and valproic acid treatment regimens in a mouse model of kidney fibrosis. 2013 Toxicol. Appl. Pharmacol. pmid:23707763
Meng F et al. Inhibition of DNA methyltransferases, histone deacetylases and lysine-specific demethylase-1 suppresses the tumorigenicity of the ovarian cancer ascites cell line SKOV3. 2013 Int. J. Oncol. pmid:23709006
Saha A et al. Synthesis and biological evaluation of a targeted DNA-binding transcriptional activator with HDAC8 inhibitory activity. 2013 Bioorg. Med. Chem. pmid:23719282
Wang H et al. Histone deacetylase inhibitors facilitate partner preference formation in female prairie voles. 2013 Nat. Neurosci. pmid:23727821
Gao B et al. Inhibition of histone deacetylase activity suppresses IFN-γ induction of tripartite motif 22 via CHIP-mediated proteasomal degradation of IRF-1. 2013 J. Immunol. pmid:23729439
Luo B et al. A possible strategy to produce pigs resistant to porcine reproductive and respiratory syndrome virus. 2013 Antiviral Res. pmid:23732571
Doñas C et al. Trichostatin A promotes the generation and suppressive functions of regulatory T cells. 2013 Clin. Dev. Immunol. pmid:23737814
Wang YG et al. Mechanisms of trichostatin A inhibiting AGS proliferation and identification of lysine-acetylated proteins. 2013 World J. Gastroenterol. pmid:23745024
Jiao F et al. Effect of dynamic DNA methylation and histone acetylation on cPouV expression in differentiation of chick embryonic germ cells. 2013 Stem Cells Dev. pmid:23750509
Pitta CA et al. Reversal of ER-β silencing by chromatin modifying agents overrides acquired tamoxifen resistance. 2013 Cancer Lett. pmid:23752064
Flight MH Behaviour: epigenetically bonded. 2013 Nat. Rev. Neurosci. pmid:23756635
Jin YX et al. Histone deacetylase inhibitor trichostatin A affects porcine oocyte maturation in vitro. 2014 Reprod. Fertil. Dev. pmid:23759302
Zhao TC et al. HDAC inhibition elicits myocardial protective effect through modulation of MKK3/Akt-1. 2013 PLoS ONE pmid:23762381
Doherty R et al. Epigenetic regulation of the innate immune response to LPS in bovine peripheral blood mononuclear cells (PBMC). 2013 Vet. Immunol. Immunopathol. pmid:23764468
Liu Y et al. MCM-2 is a therapeutic target of Trichostatin A in colon cancer cells. 2013 Toxicol. Lett. pmid:23770000
Quan H et al. Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition. 2014 Oncogene pmid:23770846
Welch MD et al. Hypomethylation of the CTGF gene locus is a common feature of paediatric pre-B acute lymphoblastic leukaemia. 2013 Br. J. Haematol. pmid:23772794
Aseem O et al. Cubilin expression is monoallelic and epigenetically augmented via PPARs. 2013 BMC Genomics pmid:23773363
Fujiki R et al. A proapoptotic effect of valproic acid on progenitors of embryonic stem cell-derived glutamatergic neurons. 2013 Cell Death Dis pmid:23788034
Chatterjee N et al. Histone deacetylase inhibitors modulate miRNA and mRNA expression, block metaphase, and induce apoptosis in inflammatory breast cancer cells. 2013 Cancer Biol. Ther. pmid:23792638
Zych J et al. The epigenetic modifiers 5-aza-2'-deoxycytidine and trichostatin A influence adipocyte differentiation in human mesenchymal stem cells. 2013 Braz. J. Med. Biol. Res. pmid:23797495
Asthana J et al. Inhibition of HDAC6 deacetylase activity increases its binding with microtubules and suppresses microtubule dynamic instability in MCF-7 cells. 2013 J. Biol. Chem. pmid:23798680
Gundersen B Pair-bonding through epigenetics. 2013 Nat. Neurosci. pmid:23799469
Diao JS et al. Histone deacetylase inhibitor reduces hypertrophic scarring in a rabbit ear model. 2013 Plast. Reconstr. Surg. pmid:23806955
Huang L et al. Down-regulation of miR-301a suppresses pro-inflammatory cytokines in Toll-like receptor-triggered macrophages. 2013 Immunology pmid:23808420
Jo SJ et al. Valproic acid promotes human hair growth in in vitro culture model. 2013 J. Dermatol. Sci. pmid:23810771
Keuser B et al. Influences of histone deacetylase inhibitors and resveratrol on DNA repair and chromatin compaction. 2013 Mutagenesis pmid:23814181
Feng T et al. Novel N-hydroxyfurylacrylamide-based histone deacetylase (HDAC) inhibitors with branched CAP group (Part 2). 2013 Bioorg. Med. Chem. pmid:23820574
Lopez-Atalaya JP et al. Genomic targets, and histone acetylation and gene expression profiling of neural HDAC inhibition. 2013 Nucleic Acids Res. pmid:23821663
Okada T et al. Identification of genes specifically methylated in Epstein-Barr virus-associated gastric carcinomas. 2013 Cancer Sci. pmid:23829175
Oksenych V et al. Histone methyltransferase DOT1L drives recovery of gene expression after a genotoxic attack. 2013 PLoS Genet. pmid:23861670
Chen CQ et al. Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer. 2013 Mol. Cell. Biochem. pmid:23867991